496 related articles for article (PubMed ID: 16253874)
1. Principles and applications of LC-MS in new drug discovery.
Korfmacher WA
Drug Discov Today; 2005 Oct; 10(20):1357-67. PubMed ID: 16253874
[TBL] [Abstract][Full Text] [Related]
2. Liquid chromatography-mass spectrometry in in vitro drug metabolite screening.
Tolonen A; Turpeinen M; Pelkonen O
Drug Discov Today; 2009 Feb; 14(3-4):120-33. PubMed ID: 19059358
[TBL] [Abstract][Full Text] [Related]
3. Quantitative analysis of pharmacokinetic study samples by liquid chromatography coupled to tandem mass spectrometry (LC-MS/MS).
Mück W
Pharmazie; 1999 Sep; 54(9):639-44. PubMed ID: 10522267
[TBL] [Abstract][Full Text] [Related]
4. Investigation of matrix effects in bioanalytical high-performance liquid chromatography/tandem mass spectrometric assays: application to drug discovery.
Mei H; Hsieh Y; Nardo C; Xu X; Wang S; Ng K; Korfmacher WA
Rapid Commun Mass Spectrom; 2003; 17(1):97-103. PubMed ID: 12478560
[TBL] [Abstract][Full Text] [Related]
5. High-throughput quantification for a drug mixture in rat plasma-a comparison of Ultra Performance liquid chromatography/tandem mass spectrometry with high-performance liquid chromatography/tandem mass spectrometry.
Yu K; Little D; Plumb R; Smith B
Rapid Commun Mass Spectrom; 2006; 20(4):544-52. PubMed ID: 16419023
[TBL] [Abstract][Full Text] [Related]
6. Current and future trends in the application of HPLC-MS to metabolite-identification studies.
Castro-Perez JM
Drug Discov Today; 2007 Mar; 12(5-6):249-56. PubMed ID: 17331890
[TBL] [Abstract][Full Text] [Related]
7. Development of a low volume plasma sample precipitation procedure for liquid chromatography/tandem mass spectrometry assays used for drug discovery applications.
Xu X; Zhou Q; Korfmacher WA
Rapid Commun Mass Spectrom; 2005; 19(15):2131-6. PubMed ID: 15988723
[TBL] [Abstract][Full Text] [Related]
8. Mass spectrometric techniques for label-free high-throughput screening in drug discovery.
Roddy TP; Horvath CR; Stout SJ; Kenney KL; Ho PI; Zhang JH; Vickers C; Kaushik V; Hubbard B; Wang YK
Anal Chem; 2007 Nov; 79(21):8207-13. PubMed ID: 17902631
[TBL] [Abstract][Full Text] [Related]
9. Narrow-bore sample trapping and chromatography combined with quadrupole/time-of-flight mass spectrometry for ultra-sensitive identification of in vivo and in vitro metabolites.
Foltz DJ; Castro-Perez J; Riley P; Entwisle JR; Baker TR
J Chromatogr B Analyt Technol Biomed Life Sci; 2005 Oct; 825(2):144-51. PubMed ID: 16213447
[TBL] [Abstract][Full Text] [Related]
10. Ultra-fast gradient vs. fast isocratic chromatography in bioanalytical quantification by liquid chromatography/tandem mass spectrometry.
Romanyshyn L; Tiller PR; Alvaro R; Pereira A; Hop CE
Rapid Commun Mass Spectrom; 2001; 15(5):313-9. PubMed ID: 11241760
[TBL] [Abstract][Full Text] [Related]
11. Applications of HILIC for targeted and non-targeted LC/MS analyses in drug discovery.
Onorato JM; Langish R; Bellamine A; Shipkova P
J Sep Sci; 2010 Mar; 33(6-7):923-9. PubMed ID: 20127913
[TBL] [Abstract][Full Text] [Related]
12. Micro LC/MS in drug analysis and metabolism studies.
Henion J; Skrabalak D; Dewey E; Maylin G
Drug Metab Rev; 1983; 14(5):961-1003. PubMed ID: 6360611
[TBL] [Abstract][Full Text] [Related]
13. Current applications of liquid chromatography/mass spectrometry in pharmaceutical discovery after a decade of innovation.
Ackermann BL; Berna MJ; Eckstein JA; Ott LW; Chaudhary AK
Annu Rev Anal Chem (Palo Alto Calif); 2008; 1():357-96. PubMed ID: 20636083
[TBL] [Abstract][Full Text] [Related]
14. Applications of hyphenated LC-MS techniques in pharmaceutical analysis.
Ermer J; Vogel M
Biomed Chromatogr; 2000 Oct; 14(6):373-83. PubMed ID: 11002275
[TBL] [Abstract][Full Text] [Related]
15. Demonstration of the capabilities of a parallel high performance liquid chromatography tandem mass spectrometry system for use in the analysis of drug discovery plasma samples.
Korfmacher WA; Veals J; Dunn-Meynell K; Zhang X; Tucker G; Cox KA; Lin CC
Rapid Commun Mass Spectrom; 1999; 13(20):1991-8. PubMed ID: 10510410
[TBL] [Abstract][Full Text] [Related]
16. Analytical strategies for identifying drug metabolites.
Prakash C; Shaffer CL; Nedderman A
Mass Spectrom Rev; 2007; 26(3):340-69. PubMed ID: 17405144
[TBL] [Abstract][Full Text] [Related]
17. Ion-suppression effects in liquid chromatography-tandem mass spectrometry due to a formulation agent, a case study in drug discovery bioanalysis.
Larger PJ; Breda M; Fraier D; Hughes H; James CA
J Pharm Biomed Anal; 2005 Sep; 39(1-2):206-16. PubMed ID: 15871916
[TBL] [Abstract][Full Text] [Related]
18. Enhanced performance test mix for high-throughput LC/MS analysis of pharmaceutical compounds.
Li S; Julien L; Tidswell P; Goetzinger W
J Comb Chem; 2006; 8(6):820-8. PubMed ID: 17096570
[TBL] [Abstract][Full Text] [Related]
19. Determination of drug concentrations in plasma by a highly automated, generic and flexible protein precipitation and liquid chromatography/tandem mass spectrometry method applicable to the drug discovery environment.
O'Connor D; Clarke DE; Morrison D; Watt AP
Rapid Commun Mass Spectrom; 2002; 16(11):1065-71. PubMed ID: 11992509
[TBL] [Abstract][Full Text] [Related]
20. LC-MS characterization of trace impurities contained in calcium folinate.
Francese G; Corana F; Meneghetti O; Marazza F
J Pharm Biomed Anal; 2005 Sep; 39(3-4):757-63. PubMed ID: 15927438
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
